Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio A Emini

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Human Gene Therapy|July 19, 2003
Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenovirusesRima Youil, Timothy J Toner, Qin Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)Anna M M van Deursen, Marlies A van Houten, Chris Webber, et al.
The Pediatric Infectious Disease Journal|September 27, 2012
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given to korean children receiving routine pediatric vaccinesDong Soo Kim, Seon Hee Shin, Hoan Jong Lee, et al.
Virology|March 9, 2004
The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6PZhi-Qiang Zhang, William A Schleif, Danilo R Casimiro, et al.
Journal of Virology|November 20, 2002
Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infectionZhi-Qiang Zhang, Tong-Ming Fu, Danilo R Casimiro, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: polar functionality and its effect on anti-HIV-1 activityJeffrey J Hale, Richard J Budhu, Sander G Mills, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butaneShrenik K Shah, Natalie Chen, Ravindra N Guthikonda, et al.
Journal of Virology|May 28, 2005
Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursorElisabetta Bianchi, Xiaoping Liang, Paolo Ingallinella, et al.
Journal of Virology|December 12, 2001
Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol geneDanilo R Casimiro, Aimin Tang, Helen C Perry, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptorK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Human Gene Therapy|July 19, 2003
Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenovirusesRima Youil, Timothy J Toner, Qin Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)Anna M M van Deursen, Marlies A van Houten, Chris Webber, et al.
The Pediatric Infectious Disease Journal|September 27, 2012
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given to korean children receiving routine pediatric vaccinesDong Soo Kim, Seon Hee Shin, Hoan Jong Lee, et al.
Virology|March 9, 2004
The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6PZhi-Qiang Zhang, William A Schleif, Danilo R Casimiro, et al.
Journal of Virology|November 20, 2002
Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infectionZhi-Qiang Zhang, Tong-Ming Fu, Danilo R Casimiro, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: polar functionality and its effect on anti-HIV-1 activityJeffrey J Hale, Richard J Budhu, Sander G Mills, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butaneShrenik K Shah, Natalie Chen, Ravindra N Guthikonda, et al.
Journal of Virology|May 28, 2005
Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursorElisabetta Bianchi, Xiaoping Liang, Paolo Ingallinella, et al.
Journal of Virology|December 12, 2001
Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol geneDanilo R Casimiro, Aimin Tang, Helen C Perry, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptorK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Pageof 9